At-home Drug of Abuse (DOA) Testing Market Size - By Type (Test Cups, Test Strips), By Sample Type (Saliva, Urine, Blood) & Global Forecast 2023

Description

List of Tables

At-home drug of abuse (DOA) testing market size is predicted to record 7% CAGR from 2023 to 2032 due to the increasing awareness and recognition of the critical role that drug screening plays in maintaining public safety and ensuring a healthy workforce. For instance, Massachusetts has launched many harm reduction programs through which test strips for xylazine is being distributed. As the drug has the capability of producing gaping skin wounds and can also cause death in case of overdose, drug screening plays a major role.

With rising prevalence of substance abuse, employers are increasingly adopting drug testing policies for employees, while parents and individuals are also using it for specific purposes. This heightened awareness has led to greater demand for at-home drug testing kits.

The overall at-home drug of abuse testing market is divided based on type, sample type, and region.

The test cups segment is predicted to observe around 7.3% CAGR from 2023 to 2032 as they offer a user-friendly, all-in-one solution for drug screening, making the process more straightforward and less prone to errors. Simultaneously, manufacturers are constantly introducing new features, such as integrated temperature strips, adulteration checks, and the ability to test for multiple drugs simultaneously. Test cups reflects the desire for cost-effective and efficient drug testing solutions that can be easily performed at home.

The blood sample segment is expected to record 7.3% CAGR from 2023 to 2032 due to the growing preference for non-invasive and painless testing methods. Traditional urine-based testing can sometimes be uncomfortable and invasive, especially in at-home settings. Blood sample testing provides an alternative that is less invasive, more discreet, and can offer accurate results. As technology continues to advance, blood sample testing is expected to become even more user-friendly and accessible, favoring the segment growth.

Asia Pacific at-home drug of abuse testing market size is anticipated to witness 8.2% CAGR through 2032 driven by an increased emphasis on health and safety, especially in the workplace and educational institutions. Governments and organizations in the region are recognizing the need for regular drug screening to combat substance abuse issues. The rapid urbanization and increased disposable income, which make at-home drug testing kits more accessible to a wider population, will positively sway the APAC market dynamics.

Product Code: 6485

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global at-home drug of abuse (DOA) testing market 360 degree synopsis, 2018 - 2032
2.2 Regional trends
2.3 Type trends
2.4 Sample type trends

Chapter 3 At-home Drug of Abuse (DOA) Testing Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Rise in the production of illicit drugs
  - 3.5.1.2 Growing government initiatives to curb drug abuse
  - 3.5.1.3 Surge in access to drugs
  - 3.5.1.4 Technological advancements and product portfolio expansion
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Inability of testing products to detect small amounts of special drugs
  - 3.5.2.2 Lack of awareness regarding drug testing
3.6 Growth potential analysis
- 3.6.1 By type
- 3.6.2 By sample type
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Competitive analysis of major market players, 2022
- 4.2.1 Abbott Laboratories
- 4.2.2 Dragerwerk AG & Co. KGaA
- 4.2.3 F. Hoffmann-La Roche AG
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022

Chapter 5 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Type (Revenue and Volume)

5.1 Key trends, by type
5.2 Test cups
5.3 Test strips
5.4 Others

Chapter 6 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Sample Type (Revenue)

6.1 Key trends, by sample type
6.2 Saliva
6.3 Urine
6.4 Blood
6.5 Others

Chapter 7 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Region (Revenue and Volume)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Switzerland
- 7.3.7 The Netherlands
- 7.3.8 Denmark
- 7.3.9 Poland
- 7.3.10 Sweden
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 New Zealand
- 7.4.7 Thailand
- 7.4.8 Vietnam
- 7.4.9 Indonesia
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Colombia
- 7.5.5 Chile
7.6 Middle East & Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Turkey

Chapter 8 Company Profiles

8.1 Abbott Laboratories
8.2 Dragerwerk AG & Co. KGaA
8.3 Assure Tech.(Hangzhou) Co., LTD
8.4 Atlas Medical GmbH
8.5 Confirm BioSciences
8.6 F. Hoffmann-La Roche AG
8.7 Siemens Healthineers AG
8.8 Thermo Fisher Scientific, Inc.
8.9 Bio-Rad Laboratories, Inc.
8.10 bioMérieux SA
8.11 Psychemedics Corporation
8.12 OraSure Technologies, Inc.